If you could vote on Brexit now which option would you choose?
   

Moderna seeks FDA EUA for Covid-19 booster vaccine


Moderna has submitted an application to the US Food and Drug Administration (FDA) to obtain emergency use authorization (EUA) for mRNA-1273.222, its BA.4/BA.5 Omicron-targeting bivalent booster vaccine for Covid-19. The submission is made for a 50µg booster dose of the vaccine for usage in adults aged 18 years and above. mRNA-1273.222 acts on the SARS-CoV-2 virus’ initial strain and the Omicron’s subvariants BA.4/BA.5.

Pharmaceutical Technology - August 24, 2022

View the full story here: https://www.pharmaceutical-technology.com/news/moderna-fda-eua-covid-19-booster-vaccine/